INMB vs LYB · rev $50.0K vs P/E 21, rev $16.37B
INmune Bio Inc (INMB) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
INMB currently screens at market cap $33.5M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the INMB and LYB stock pages for the full models.
Not investment advice.